EP3432861
NOTKUN Á INSÚLÍNI TIL AÐ STUÐLA AÐ MAGATÆMINGU
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
24.3.2017EP published:
12.7.2023EP application number:
17771247.8
EP translation filed:
29.8.2023Grant published:
15.9.2023EPO information:
European Patent Register
Max expiry date:
23.3.2037Expiry date:
23.3.2027Next due date:
31.3.2027
Title in English:
USE OF INSULIN FOR PROMOTING GASTRIC EMPTYINGLanguage of the patent:
English
Timeline
Today
24.3.2017EP application
12.7.2023EP Publication
29.8.2023Translation submitted
15.9.2023Registration published
23.3.2027Expires
Owner
Name:
Elgan Pharma Ltd.Address:
New Generation Technologies NGT3 13 Wadi El-Haj Street, 1711102 Nazareth, IL
Inventor
Name:
ATAROT, TalAddress:
4061401 Tel-Mond, IL
Name:
OLSHANSKY, MichalAddress:
6233112 Tel-Aviv, IL
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201662312473 PDate:
24.3.2016Country:
US
Classification
Categories:
A61K 9/02, A61K 9/14, A61K 9/20, A61K 9/48, A61K 38/28, C07K 14/62, A61P 1/14, A61K 9/00, A61K 45/06
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 20.3.2024
Expires: 23.3.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 9
Paid: 25.3.2025
Expires: 23.3.2026
Payer: G.H. Sigurgeirsson ehf.
Number: 10
Paid: 19.3.2026
Expires: 23.3.2027
Payer: G.H. Sigurgeirsson ehf.